• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Health Tech

phoenix rising from the flames
Biotech

Takeda leader says AI gave early-stage asset a 'phoenix' rebirth

Takeda's R&D head shares about the drugmaker's AI implementation across all discovery efforts and warns against long-term risks for U.S. innovation.
Gabrielle Masson Jan 13, 2026 6:16am
AI

Lilly, Nvidia form new AI co-innovation lab with $1B investment

Jan 12, 2026 10:00am
Robot hands with a pieces of the puzzle

GSK inks model deal in $50M bet on Noetik's cancer AI platform

Jan 8, 2026 10:30am
future forward-looking 2026 new year

Pharma's 'urgent need for reinvention': PwC's call to action

Jan 8, 2026 6:00am
Three blocks displaying from left to right a person a handshake and another person

InduPro nabs 2nd Big Pharma deal with $950M Lilly pact

Jan 7, 2026 3:52pm
A ballpoint pen rests on top of a stack of documents ready for signing

Boehringer continues kidney dealmaking with $120M Variant pact

Jan 6, 2026 10:45am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings